The DEA is "out of touch" and resistant to reform, stated Ben Kovler. Yet, amid this uncertainty, MMJ International Holdings has charted a distinct course-one rooted in pharmaceutical rigor-that's positioning the company as a trailblazer in the medical cannabis space.

The Department of Justice (DOJ) has announced that it will no longer defend statutory protections that currently shield Administrative Law Judges (ALJs) from removal. This significant shift is expected to bolster MMJ International Holdings' ongoing lawsuit against the Drug Enforcement Administration (DEA), which has been criticized for stalling MMJ's application to cultivate pharmaceutical-grade marijuana for medical research.

• FDA-Compliant Clinical Trials:
  MMJ's innovative soft gelatin THC-CBD capsule, known as MMJ-002, is undergoing the rigorous FDA approval process to validate the safety and efficacy of cannabis-derived therapeutics for use in human clinical trials for Huntington's disease patients.

MMJ is currently engaged in litigation with the Drug Enforcement Administration (DEA). The company contends that the DEA has obstructed domestic cannabis research despite the Right To Try and the Medical Marijuana Research Expansion Act. MMJ accuses the DEA of bias in restricting MMJ to cultivate its proprietary marijuana cultivars necessary for research and pharmaceutical drug manufacturing. A pending federal court ruling in Rhode Island will set a significant precedent, challenging DEA authority and potentially easing regulatory barriers for MMJ's future cannabinoid drug development.

MEET DEA DIVERSION Thomas Prevoznik - The man behind the DEA marijuana scam- He Defied Presidential Mandates on Cannabis Research and Right to Try 

"Is the DEA another failed government agency? MMJ will continue our litigation efforts until the Drug Enforcement Agency acts in accordance with the law," stated Duane Boise
 

DEA Admin Anne Milgram Resigns, Tom Prevoznik and Matt Strait Next? Bureaucratic Bias is Over.

Duane Boise MMJ's CEO stated "The DEA's administrative law judge (ALJ) system has been accused of functioning as a ‘judge, jury, and executioner,’ with Anne Milgram the DEA's administrator controlling the prosecutorial and adjudicatory roles, raising concerns about due process and fairness for small entities like MMJ. As this case unfolds, the potential ramifications for the DEA's operations - and marijuana rescheduling hearings - are profound."

Duane Boise, President of MMJ BioPharma Cultivation, stated, "I think most Americans want judges who don't mind telling the truth and don't mind saying we're wrong. Unlike the DEA's arrogant attitude of, if we make a mistake, we won't be called on it, however MMJ is doing exactly that. The most immature thing you can do is say, 'no, no, I didn't make a mistake.' The mature thing to do, that all adults learn to do in this country is to say, 'oops, that was a mistake. I'm going to fix it. I'm sorry.'"